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In a previous report (1) it was shown that after a single oral
dose of potassium bismuth tartrate administered to guinea pigs,
maximum absorption was reached at twenty-four hours in the
liver, spleen and kidney. In this same article it was also shown
that the free acidity and pH of the stomach and the pH of the
intestines of guinea pigs show a sufficient analogy to the human
gastro-intestinal tract to assume that comparable results may be
expected and experienced in man.
The fact that a detectable amount of bismuth was deposited in
the liver, kidney and spleen led us to continue our experiments
giving daily doses of potassium bismuth tartrate to guinea pigs
over varying periods of time in order to determine the cumulative
effect through studies of the content of these various organs.
Kolmer (2) suggests a dosage of 0.02 gram of potassium bismuth
tartrate per kilogram of body weight in the treatment of experi-
mental rabbit syphilis. This dosage was used in one group of
animals while another group was chosen in which 0.04 gram of
potassium bismuth tartrate per kilogram of body weight was
administered. No toxic effect was experienced with the first
group, all animals living to complete the experiment. Of the
latter group, however, about one out of every five pigs died
within seven days. Those that survived, however, continued to
receive 0.04 gram of potassium bismuth tartrate per kilogram of
body weight daily.
The method of administration was the same as in the previous
experiment, that is, 0.02 or 0.04 gram of bismuth salt was dissolved
in one cubic centimeter of distilled water and the daily dosage
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adjusted according to the weight of the individual animal. In
every instance the dissolved bismuth salt was administered early
in the morning before the morning feeding. Again the free
acidity and pH of the stomach and the pH of the intestine were
tested in a group of animals before the morning feeding and
found to be entirely similar to those of man and to those of the
former experiment. All tests were made by the La Motte method.
The first group of twenty animals was given 0.02 gram of
potassium bismuth tartrate per kilogram of body weight daily
TABLE 1
Daily potassium bismuth tartrate 0.02 gram per kilogram—4-day
ANIMAL
NUM
BEN
1
2
3
4
WEIGHT
OP
ANIMAL
354
408
384
278
WEIGHT
OF
LIVER
15
17
14
14
Bi PER
GRAM
0.1704
0.1648
0.1785
0.1666
Bi
TOTAL
LIVER
2.5560
2.8016
2.4990
2.3324
WEIGHT
OF
KIDNEY
1.0
1.2
1.0
0.8
Bi PER
GRAM
0.1648
0.1442
0.1530
0.2012
Bi
TOTAL
KIDNEY
0.1648
0.1730
0.1530
0.1612
WEIGHT
OP
SPLEEN
0.7
0.9
0.7
0.6
RI PER
GRAM
0.1530
0.1390
0.1930
0.2340
Bi
TOTAL
SPLEEN
0.1072
0.1250
0.1351
0.1401
TABLE 2
Daily potassium bismuth tartrate 0.02 gram per kiiogram—7 -day
ANIMAL
NUM
BEN
5
6
7
8
WEIGHT
OF
ANIMAL
287
304
298
340
WEIGHT
OF
LIVER
13
15
14
15
Bi PER
GRAM
0.1785
0.1530
0.1578
0.1515
Bi
TOTAL
LIVER
2.3205
2.2950
2.2092
2.2725
WEIGHT
OF
KIDNEY
0.9
1.0
1.0
1.1
Bi PER
GRAM
0.1530
0.1442
0.1315
0.1292
Bi
TOTAL
KIDNEY
0.1376
0.1442
0.1315
0.1421
WEIGHT
OF
SPLEEN
0.7
0.9
0.8
0.9
Bi PER
GRAM
0.1420
0.1100
0.1080
0.0960
Bi
TOTAL
SPLEEN
0.0993
0.0993
0.0862
0.0872
for four, seven, fourteen, twenty-one and twenty-eight days.
Each group of four animals were sacrificed at the end of their
respective periods and the liver, kidneys and spleen removed.
The bismuth content of these organs was determined according to
the method of Leonard (3) using a Kleet colorimeter after the
wet combustion and transformation of the bismuth to potassium
bismuth iodide.
Upon examination of the first five tables it is seen that there
is little variation in the total amount of bismuth deposited at the
end of the four day period and at the end of the twenty-eight day
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period. At the end of four days the average amount of bismuth
per gram of liver substance was 0.17 mg. At the end of twenty-
eight days there was only 0.20 mg. per gram of liver substance.
The amount of bismuth deposited in the kidney and spleen showed
TABLE 3
Daily potassium bismuth tartrate O.0f2 gram per kilogram—i 4-day
ANIMAL
RUM-
HER
9
10
11
12
WEIGHT
OF
ANIMAL
294
304
336
304
WEIGHT
OF
LIVHR
14
14
15
14
Bi PER
GRAM
0.1807
0.1923
0.2112
0.2027
Bi
TOTAL
LIVER
2.5298
2.6922
3.1680
2.8378
WEIGHT
OF
KIDNEY
0.9
0.9
1.1
1.0
Bi
GRAM
0.1460
0.1590
0.1515
0.1485
Bi
TOTAL
KIDNEY
0.1315
0.1428
0.1667
0.1485
WEIGHT
OF
SPLEEN
0.7
0.7
0.9
0.8
Bi PER
GRAM
0.1320
0.1390
0.1120
0.1240
Bi
TOTAL
SPLEEN
0.0927
0.0974
0.1013
0.0993
TABLE 4
Daily potassium bismuth tartrate O.OP gram per kilogram—21-day
ANIMAL
HUM-
BER
13
14
15
16
WEIGHT
OF
ANIMAL
297
314
365
290
WEIGHT
OF
LIVER
13
14
16
13
Bi PER
GRAM
0.1898
0.1948
0.2054
0.1923
Bi
TOTAL
LIVER
2.4674
2.7272
3.2864
2.4999
WEIGHT
OF
KIDNEY
0.9
1.1
1.2
1.0
Bi PER
GRAM
0.1700
0.1612
0.1666
0.1578
Bi
TOTAL
KIDNEY
0.1530
0.1773
0.1999
0.1578
WEIGHT
OF
SPLEEN
0.7
0.9
0.8
0.7
Bi PER
GRAM
0.1350
0.1140
0.1310
0.1420
Bi
0.0943
0.1027
0.1049
0.0993
TABLE 5
Daily potassium bi8muth tartrate O.O gram per kilo gram—8 -day
ANIMAL
NUM
HER
17
18
19
20
WEIGHT
OF
ANIMAL
348
312
306
322
WEIGHT
OF
LIVER
14
14
13
14
Bi PER
GRAM
0.1973
0.2027
0.1948
0.2054
El
TOTAL
LIVER
2.7622
2.8378
2.5324
2.8756
WEIGHT
OF
KIDNEY
1.2
1.0
1.0
1.2
Bi PER
GRAM
0.1648
0.1685
0.1648
0.1704
Bi
TOTAL
KIDNEY
0.1973
0.1685
0.1648
0.2045
WEIGHT
OF
SPLEEN
0.8
0.8
0.7
0.9
Bi PER
GRAM
0.1280
0.1270
0.1450
0.1150
Bi
0.1027
0.1020
0.1013
0.1034
a corresponding very slight increase from the four to the twenty-
eight day period.
In tables 6 to 10 inclusive, after 0.04 gram of potassium bismuth
tartrate per kilogram of body weight was administered to experi-
mental animals, it was found that after the four day period an
average of 0.2258 mg. of bismuth was deposited per gram of
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liver substance and that after the twenty-eight-day period 0.2105
mg. of bismuth per gram of liver substance was deposited. The
spleens and kidneys in this second group of experimental animals
also showed similar slight increases.
TABLE 6
Daily potassium bismuth tartrate 0.04 gram per kilogram—4-day
ANIMAL
NUM-
BEE
21
22
23
24
WEIGHT
OF
ANIMAL
295
360
418
321
WEIGHT
OF
LIVER
14
16
15
14
Bi PER
GRAM
0.2439
0.2027
0.2308
0.2143
Bi
TOTAL
LIVER
3.4146
3.2432
3.4620
3.0002
WEIGHT
OF
KIDNEY
0.9
1.1
1.0
0.9
Bi PER
GRAM
0.2170
0.1578
0.1875
0.2110
Bi
TOTAL
KIDNEY
0.1957
0.1736
0.1875
0.1898
WRIGHT
OF
SPLEEN
0.8
0.8
0.8
0.7
Bi PER
GRAM
0.1540
0.1770
0.1840
0.2350
TOTAL
SPLEEN
0.1235
0.1414
0.1471
0.1648
TABLE 7
Daily potassium bismuth tartrate 0.04 gram per kilo gram—7 -day
ANIMAL
NUM-
BER
25
26
27
28
WEIGHT
OF
ANIMAL
275
296
302
280
WEIGHT
OF
LIVER
14
14
14
13
Bi PEE
GRAM
0.2421
0.1875
0.1724
0.1785
Bi
TOTAL
LIVER
3.3894
2.6250
2.4136
2.3205
WEIGHT
OF
KIDNEY
0.9
1.0
1.0
0.9
Bi VER
GRAM
0.2350
0.1530
0.1471
0.1600
Bi
TOTAL
KIDNEY
0.2111
0.1530
0.1471
0.1440
WEIGHT
OP
SPLEEN
0.7
0.9
0.8
0.7
Bi PER
GRAM
0.1470
0.1260
0.1160
0.1350
Bi
TOTAL
SPLEEN
0.1027
0.1136
0.0926
0.0949
TABLE 8
Daily potassium bismuth tartrate 0.04 gram per kilogram—i 4-day
ANIMAL
NIIM-
BEE
29
30
31
32
WEIGHT
OF
ANIMAL
276
352
297
311
WEIGHT
OF
LIVER
13
14
13
15
Bi PER
GRAM
0.1923
0.2143
0.2174
0.2112
Bi
TOTAL
LIVER
2.4999
3.0002
2.8262
3.1680
WEIGHT
OP
KIDNEY
0.8
1.0
0.9
1.0
Bi PER
GRAM
0.1910
0.1648
0.1720
0.1666
Bi
TOTAL
KIDNEY
0.1530
0.1648
0.1546
0.1666
WEIGHT
OF
SPLEEN
0.6
0.9
0.8
0.8
Bi R
GRAM
0.1730
0.1250
0.1340
0.1370
Bi
TOTAL
SPLEEN
0.1041
0.1127
0.1071
0.1095
In comparing the tables of the various groups of animals to
which 0.02 and 0.04 gram of bismuth were administered, it is
found that there is so slight a difference in the amount of deposit
that the increased dosage apparently plays no important part.
In fact, upon examination the amount of bismuth per gram in the
liver, kidney and spleen after the administration of 0.02 gram of
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bismuth at the end of the four-day period is very little less than
that per gram of liver, kidney or spleen substance at the end of
the twenty-eight-day period after the administration of 0.04
gram per kilogram.
TABLE 9
Daily potassium bismuth tartrate 0.04 gram per kilogram—1 -day
ANIMAL
NITM-
BEE
33
34
35
36
WEIGHT
OF
ANIMAL
301
376
356
275
WEIGHT
OF
LIVER
14
15
14
13
Bi PER
GRAM
0.2143
0.2388
0.2237
0.2174
Bi
TOTAL
LIVER
3.0002
3.4620
3.1318
2.8262
WEIGHT
OF
KIDNEY
1.0
1.4
1.3
0.9
Bi PER
GRAM
0.1648
0.1685
0.1785
0.1890
Bi
TOTAL
KIDNEY
0.1648
0.2359
0.2321
0.1704
WEIGHT
OF
SPLEEN
0.7
0.9
0.9
0.7
Bi PER
GRAM
0.1590
0.1280
0.1300
0.1540
Bi
TOTAL
SPLEEN
0.1111
0.1154
0.1171
0,1079
TABLE 10
Daily potassium bismuth tart rate 0.04 gram per kilo gram—28-day
ANIMAL
NUM
BEE
37
38
39
40
WEIGHT
OF
ANIMAL
288
308
317
334
WEIGHT
OF
LIVER
13
13
14
14
Bi PER
GRAM
0.2205
0.2143
0.2000
0.2174
Bi
TOTAL
LIVER
2.8665
2.7859
2.8000
3.0336
WRIGHT
OF
KIDNEY
0.8
0.9
1.1
1.1
Bi PER
GRAM
0.2160
0.1940
0.1807
0.1829
Bi
TOTAL
KIDNEY
0.1724
0.1744
0.1988
0.2012
WEIGHT
OF
SPLEEN
0.6
0.6
0.8
0.9
Bi PER
GRAM
0.1810
0.1910
0.1490
0.1380
Bi
TOTAL
SPLEEN
0.1087
0.1145
0.1190
0.1240
DISCUSSION
A careful study of the tables will show that apparently experi-
mental animals reach a point where no more bismuth is deposited
in the liver, kidney and spleen regardless of dosage or length of
administration. This may be shown most strikingly when com-
paring the animals given 0.02 gram of bismuth for four days with
those given 0.04 gram for twenty-eight days. In the first instance
the average of the four animals per gram of liver substance was
0.1700 mg. of bismuth. In the second instance, even after the
dosage was doubled and the drug administered for twenty-eight
days instead of four, the average was only 0.2105 mg. per gram of
liver substance. This would indicate that there is apparently no
accumulation of the bismuth salt in the organs tested.
In 1933 Levaditi (4) in his review of the bismuth literature
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makes the statement "That one should not transpose into the
domaine of human therapy the bismuth posology established by
experiments on the rabbit, at the risk of endangering even the
life of the patient." Realizing that perhaps the experiments
shown above transgress this precept of Levaditi, it is felt that this
is the first actual proof of the amount of bismuth deposited in
certain organs after oral administration and that the proper inter-
pretation of these results will lead to a more thorough and careful
consideration of the subject of the oral administration of bismuth
salts before they are allowed to be used "at the risk of endangering
the life of the patient." Kolmer (2), recognizing the danger
to the patient that might accrue from the misinterpretation of
his experiment in rabbit syphilis, gives very definite indications
for this type of therapy and his indications do not conflict with
the present methods of active treatment which are to-day known
to control early and intermediate syphilis. Brigham (5), on
the other hand, using a glycerite of bismuth, reports beneficial
results in two cases which had become Wasserman fast and in
other cases treated with arsphenamine and iodides, showing im-
provement both clinically and serologically. Moore (6) in his
review of the recent literature of 1935 discusses the oral admin-
istration of bismuth; and speaking of the work of Serefis and
Mulzer (7) states as billows: "I have discussed these articles in
detail because of the authority represented by the authors'
names, because unjustified clinical trial preceded adequate ex-
perimentation (or at least adequate presentation of that experi-
mentation) and because, on the basis of thoroughly inadequate
evidence of the value of the method or the preparation employed,
commercial distribution of 'bismutrat' has already begun abroad
and may shortly occur in this country" and again after discussion
of Kolmer's (2) work "Neither the work of Mulzer and Serefis
nor that of Kolmer can be accepted as justifying a clinical trial
of this method." Hardly had Moore's warning about "bis-
mutrat" been published than Rein and Sulzberger (8) experi-
mented with bismutrat in rabbit syphilis and reported that this
preparation is absorbed from the intestinal tract and that there
is some possibility of successful primary abortion with it, con-
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eluding however, that more experimental work is necessary in
both rabbit and human syphilis. In the same journal Kemp and
Rosahn (9) showed complete failure in five and six rabbits with
syphilis treated with bismutrat. Six animals fed bismuth sodium
iron citrate showed no change in the course of their infection.
Seven of eight rabbits to which potassium bismuth tartrate was
given showed active treponema after treatment. They conclude
that their experiments support the observation of Serefis (and
incidentally Levaditi) that it is impossible to use the syphilitic
rabbit in determining the value of bismuth in the oral treatment of
syphilis in man. They conclude that "Until there is available
a more adequate method of determining the value of this form
of treatment, it is unwise to suggest the oral use of bismuth salts
in the treatment of late syphilis and reprehensible to suggest their
use in the treatment of early syphilis."
More recently Hanzlik, Lehman and Richardson (10) report
the use of sodium bismuthate given intramuscularly and orally in
the treatment of experimental rabbit syphilis and in human
syphilis. Using a dosage of 0.2 gram which represents 0.14
gram of metallic bismuth they were able to show quantitative
absorption from an isolated intestinal ioop of an experimental
animal. The amount absorbed, however, is in our opinion not
sufficient to warrant the use of this substance in the treatment of
early or intermediate syphilis. Their report of the oral use of
sodium bismuthate is taken from the clinic of Dr. C. W. Barnett.
He reports two cases of extensive secondary syphilitic eruptions
given 200 mg. of sodium bismuthate three times daily by mouth.
Dark field examination of the lesions became negative in 2 to 3
days. Two other patients with gummata of the nasopharynx and
of the nose were given 0.6 gram daily and showed complete healing
in 6 and 3 weeks respectively.
DISCUSSION AND CONCLUSIONS
1. Following the daily administration of potassium bismuth
tartrate in dosages of 0.02 and 0.04 gram per kilogram body
weight, there was little more deposit in the liver, kidney and
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spleen at the end of the twenty-eight-day period than at the end
of the four-day period.
2. Determinations at the various four- to twenty-eight-day
periods showed there was little difference in the amount of
bismuth deposited after the administration of 0.02 gram as com-
pared with the amount deposited after 0.04 gram per kilogram
body weight.
3. The work done on experimental syphilis with the adminis-
tration of various oral bismuth preparations is as yet wholly
inadequate and permits no conclusion other than that much more
experimental work is imperative; such experimental work should
include studies of the rate and amount of bismuth absorbed from
the various oral preparations. These factors shouldbe thoroughly
investigated in normal experimental animals.
4. The few clinical cases reported improved following the oral
administration of bismuth may serve only to mislead and give
a false sense of security to the undertrained or unwary physician
who is looking for an easy method of treatment of syphilis.
5. It is unfortunate that upon the basis of insufficient pre-
liminary experimentation, commercial preparations have been
recommended for clinical use in this country and abroad, based
only on a group of reports which are conflicting in results and in
most instances inadequate in fundamental facts.
6. In combatting syphilis it is imperative that each and every
syphilologist not only practice the known, recognized and re-
liable methods of treatment but also discourage the clinical use of
others until they have been proven by complete, carefully con-
trolled laboratory, animal and clinical experimentation. Some
patients are already asking about the "new" treatment by mouth
for syphilis. This form of unwarranted enthusiasm must be dis-
couraged; and stopping premature recommendations of new,
untried commercial preparations should form an essential part of
the present campaign to educate the public in the prophylaxis and
treatment of syphilis.
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